China-Based Heparin Prompts Outsourcing Worries
This article was originally published in PharmAsia News
Executive Summary
The problems with Chinese-made ingredients for the heparin blood-thinner drug highlight one peril of drug makers outsourcing production elements. Heparin recalls have been announced in six countries where regulators have been moved to consider the source, China, which itself has increased drug safety efforts. China and India are among developing countries still developing their systems for safeguarding drug production. One American safe-medicine advocate said the heparin problem was "just the tip of the iceberg" where sensitive drugs are concerned. (Click here for more